The contribution of reactive oxygen species and p38 mitogen‐activated protein kinase to myofilament oxidation and progression of heart failure in rabbits
Open Access
- 25 June 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (6) , 1408-1416
Abstract
Background and purpose: The formation of reactive oxygen species (ROS) is increased in heart failure (HF). However, the causal and mechanistic relationship of ROS formation with contractile dysfunction is not clear in detail. Therefore, ROS formation, myofibrillar protein oxidation and p38 MAP kinase activation were related to contractile function in failing rabbit hearts.Experimental approach and key results: Three weeks of rapid left ventricular (LV) pacing reduced LV shortening fraction (SF, echocardiography) from 32 ± 1% to 13 ± 1%. ROS formation, as assessed by dihydroethidine staining, increased by 36 ± 8% and was associated with increased tropomyosin oxidation, as reflected by dimer formation (dimer to monomer ratio increased 2.28 ± 0.66‐fold in HF vs. sham, P < 0.05). Apoptosis (TdT‐mediated dUTP nick end labelling staining) increased more than 12‐fold after 3 weeks of pacing when a significant increase in the phosphorylation of p38 MAP kinase and HSP27 was detected (Western blotting). Vitamins C and E abolished the increases in ROS formation and tropomyosin oxidation along with an improvement of LVSF (19 ± 1%, P < 0.05 vs. untreated HF) and prevention of apoptosis, but without modifying p38 MAP kinase activation. Inhibition of p38 MAP kinase by SB281832 counteracted ROS formation, tropomyosin oxidation and contractile failure, without affecting apoptosis.Conclusions and implications: Thus, p38 MAP kinase activation appears to be upstream rather than downstream of ROS, which impacts on LV function through myofibrillar oxidation. p38 MAP kinase inhibition is a potential target to prevent or treat HF.Keywords
This publication has 46 references indexed in Scilit:
- A CaPful of mechanisms regulating the mitochondrial permeability transitionJournal of Molecular and Cellular Cardiology, 2009
- Resolution of Established Cardiac Hypertrophy and Fibrosis and Prevention of Systolic Dysfunction in a Transgenic Rabbit Model of Human Cardiomyopathy Through Thiol-Sensitive MechanismsCirculation, 2009
- Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5Free Radical Biology and Medicine, 2008
- G Protein–Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart FailureCirculation Research, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Potential of p38-MAPK inhibitors in the treatment of ischaemic heart diseasePharmacology & Therapeutics, 2007
- Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion ProductionJournal of Cardiovascular Pharmacology, 2007
- REACTIVE OXYGEN SPECIES IN CARDIAC SIGNALLING: FROM MITOCHONDRIA TO PLASMA MEMBRANE ION CHANNELSClinical and Experimental Pharmacology and Physiology, 2006
- p38 Mitogen Activated Protein Kinase Mediates Both Death Signaling and Functional Depression in the HeartThe Annals of Thoracic Surgery, 2005
- Role of p38? MAPK in cardiac apoptosis and remodeling after myocardial infarctionJournal of Molecular and Cellular Cardiology, 2005